Skip to content


Pharmacy Update: Zinbryta Discontinued

On March 2, 2018, the manufacturers of Zinbryta (daclizumab) – a drug used in the treatment of some forms of multiple sclerosis – announced that they would stop making the drug because of concerns about serious side effects.

Product Exclusions, Effective July 1 and August 1, 2018

The changes in this bulletin apply to all groups that use the PAI Preferred Drug List.

Preferred Blue Logo Change

PAI is excited to introduce a new Preferred Blue provider (PPO) network logo.

Drug List Changes Effective July 1, 2018

The changes in this bulletin go into effect July 1, 2018, unless noted otherwise. They apply to PAI groups that use the Caremark Preferred Drug List.

Opioid Management Program – Effective April 1, 2018

The Pharmacy & Therapeutics (P&T) Committee has worked diligently to develop an Opioid Management Program slated to begin April 1, 2018.

Integrated Commercial Health & Workers' Compensation Solution for Large Employers

Bardavon Health Innovations and Planned Administrators, Inc. to Launch Integrated Commercial Health and Workers’ Compensation Solution

Pharmacy Changes Effective January 1, 2018

Emergency Procedures for Prescription Refills

PAI Announces: Charlie Sears, New PAI Sales Executive

PAI is Proud to Offer Property and Casualty Administrative Services

  • Page 1 of 1
  • 1